Access-site-related complications complication with respect to surgical era
| Era 2020–2021 (n = 102) N (%) . | Era 2022–2023 (n = 274) N (%) . | P-Value . | |
|---|---|---|---|
| Single ProglideTM | 67 (65.7) | 251 (91.6) | <0.001 |
| Additional ProglideTM | 35 (34.3) | 23 (8.4) | <0.001 |
| Additional AngioSeal | 45 (44.1) | 79 (28.8) | 0.007 |
| Device failure requiring open groin revision | 12 (11.7) | 8 (2.9) | 0.002 |
| Late groin complications | 2 (2) | 0 (0) | |
| Vascular occlusion | 1 | 0 | |
| Lymph fistula | 1 | 0 | |
| Healing disorder | 0 | 0 | |
| Hospital stay (days) | 12.5 ± 7.5 | 11.3 ± 6 | 0.333 |
| Era 2020–2021 (n = 102) N (%) . | Era 2022–2023 (n = 274) N (%) . | P-Value . | |
|---|---|---|---|
| Single ProglideTM | 67 (65.7) | 251 (91.6) | <0.001 |
| Additional ProglideTM | 35 (34.3) | 23 (8.4) | <0.001 |
| Additional AngioSeal | 45 (44.1) | 79 (28.8) | 0.007 |
| Device failure requiring open groin revision | 12 (11.7) | 8 (2.9) | 0.002 |
| Late groin complications | 2 (2) | 0 (0) | |
| Vascular occlusion | 1 | 0 | |
| Lymph fistula | 1 | 0 | |
| Healing disorder | 0 | 0 | |
| Hospital stay (days) | 12.5 ± 7.5 | 11.3 ± 6 | 0.333 |
Data are given as mean and standard deviation or median with interquartile range, and dichotomous data as count (%).
Access-site-related complications complication with respect to surgical era
| Era 2020–2021 (n = 102) N (%) . | Era 2022–2023 (n = 274) N (%) . | P-Value . | |
|---|---|---|---|
| Single ProglideTM | 67 (65.7) | 251 (91.6) | <0.001 |
| Additional ProglideTM | 35 (34.3) | 23 (8.4) | <0.001 |
| Additional AngioSeal | 45 (44.1) | 79 (28.8) | 0.007 |
| Device failure requiring open groin revision | 12 (11.7) | 8 (2.9) | 0.002 |
| Late groin complications | 2 (2) | 0 (0) | |
| Vascular occlusion | 1 | 0 | |
| Lymph fistula | 1 | 0 | |
| Healing disorder | 0 | 0 | |
| Hospital stay (days) | 12.5 ± 7.5 | 11.3 ± 6 | 0.333 |
| Era 2020–2021 (n = 102) N (%) . | Era 2022–2023 (n = 274) N (%) . | P-Value . | |
|---|---|---|---|
| Single ProglideTM | 67 (65.7) | 251 (91.6) | <0.001 |
| Additional ProglideTM | 35 (34.3) | 23 (8.4) | <0.001 |
| Additional AngioSeal | 45 (44.1) | 79 (28.8) | 0.007 |
| Device failure requiring open groin revision | 12 (11.7) | 8 (2.9) | 0.002 |
| Late groin complications | 2 (2) | 0 (0) | |
| Vascular occlusion | 1 | 0 | |
| Lymph fistula | 1 | 0 | |
| Healing disorder | 0 | 0 | |
| Hospital stay (days) | 12.5 ± 7.5 | 11.3 ± 6 | 0.333 |
Data are given as mean and standard deviation or median with interquartile range, and dichotomous data as count (%).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
